For the study, researchers from both agencies analyzed data submitted by 28 E.U. member states on multiple strains of bacteria with known drug-resistance commonly detected in humans and animals. Analysis revealed nearly 30 percent of Salmonella isolates extracted from humans displayed multidrug resistance. However, experts also found resistance to antimicrobials used to treat severe human cases of Salmonella infection remained low.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox
“It is of particular concern that some common types of Salmonella in humans, such as monophasic Salmonella Typhimurium, exhibit extremely high multidrug resistance,” said Dr. Mike Catchpole, the chief scientist at the ECDC. “Prudent use of antibiotics in human and veterinary medicine is extremely important to address the challenge posed by antimicrobial resistance. We all have a responsibility to ensure that antibiotics keep working.”
More articles on infection control:
California Red Cross emergency center sees outbreak of potential norovirus
Study: Listeria linked to miscarriage in early pregnancy
Anti-vaccine movement gains traction in Texas
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
